You have to look at where the additional shares are going.. In...

You have to look at where the additional shares are going..

In this case the bulk of new shares on issue are due to acquiring the remaining 45% of MCL.

If you attribute the lion share of our current market cap value to our 55% stake in MCL & very little or nothing in our bauxite holdings it is reasonable to think the markets would place an equal value on the aquired further 45% of MCL? No?

You also have the aquisition of T12 food groups with a logistical footprint already laid in Asia in addition to our proposed partnerships with Medcann & BioHealth.

This means increased assets & a streamlined business model for those extra shares.

What you value MCL at is not of concern.

The markets will re-rate CGB upon relisting as they see fit however at the present minute they are correct to assume minimal dilution in sp based on last trading valuations.

Good day Sir.

Bada bing..Bada boom.